Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Seminars in Thrombosis and Hemostasis|October 1, 1983
Impact of automation on the quantitation of low molecular weight markers of hemostatic defectsJ Fareed, J M Walenga, R L Bick, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1984
Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequenceJ M Walenga, J Fareed, G Mariani, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and managementJ Fareed, D A Hoppensteadt, F Leya, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Vascular damage correlates between heparin-induced thrombocytopenia and the antiphospholipid syndromeJ M Walenga, K Michal, D Hoppensteadt, et al.
Seminars in Hematology|February 4, 1999
Antithrombin agents as anticoagulants and antithrombotics: implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
Pageof 9